These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 38254833)

  • 1. Ocular Surface Side Effects of Novel Anticancer Drugs.
    Vitiello L; Lixi F; Coco G; Giannaccare G
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of anticancer drugs on the ocular surface.
    Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K
    Ocul Surf; 2020 Jul; 18(3):403-417. PubMed ID: 32344148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular surface complications of local anticancer drugs for treatment of ocular tumors.
    Moon J; Choi SH; Lee MJ; Jo DH; Park UC; Yoon SO; Woo SJ; Oh JY
    Ocul Surf; 2021 Jan; 19():16-30. PubMed ID: 33238207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced ocular disorders.
    Li J; Tripathi RC; Tripathi BJ
    Drug Saf; 2008; 31(2):127-41. PubMed ID: 18217789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Known and novel ocular toxicities of biologics, targeted agents, and traditional chemotherapeutics.
    Kunkler AL; Binkley EM; Mantopoulos D; Hendershot AJ; Ohr MP; Kendra KL; Davidorf FH; Cebulla CM
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1771-1781. PubMed ID: 31098752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular toxicity of systemic anticancer chemotherapy.
    Omoti AE; Omoti CE
    Pharm Pract (Granada); 2006 Apr; 4(2):55-9. PubMed ID: 25247000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
    Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
    Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular toxicity and cancer chemotherapy. A review.
    al-Tweigeri T; Nabholtz JM; Mackey JR
    Cancer; 1996 Oct; 78(7):1359-73. PubMed ID: 8839540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular Side Effects of Common Systemic Medications and Systemic Side Effects of Ocular Medications.
    Syed MF; Rehmani A; Yang M
    Med Clin North Am; 2021 May; 105(3):425-444. PubMed ID: 33926639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular disorders of anticancer drugs--ocular side effects].
    Kashiwagi H
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1639-44. PubMed ID: 20841924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular and systemic adverse effects of ophthalmic and non ophthalmic medications.
    Izazola-Conde C; Zamora-de la Cruz D; Tenorio-Guajardo G
    Proc West Pharmacol Soc; 2011; 54():69-72. PubMed ID: 22423585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular complications of systemic medications.
    Blomquist PH
    Am J Med Sci; 2011 Jul; 342(1):62-9. PubMed ID: 21139494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.
    Pron G; Ieraci L; Kaulback K;
    Ont Health Technol Assess Ser; 2011; 11(5):1-89. PubMed ID: 23074417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for advanced gastric cancer.
    Wagner AD; Syn NL; Moehler M; Grothe W; Yong WP; Tai BC; Ho J; Unverzagt S
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD004064. PubMed ID: 28850174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavonoid and cannabinoid impact on the ocular surface.
    Bielory L; Tabliago NRA
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):482-492. PubMed ID: 32796166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Relevant Models for Ocular Inflammatory Diseases.
    Gilger BC
    ILAR J; 2018 Dec; 59(3):352-362. PubMed ID: 29474707
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.